XiuQin

XiuQin | Joined since 2024-04-11

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

8

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
8
Past 30 days
7
Past 7 days
0
Today
0

User Comments
Stock

1 week ago | Report Abuse

SELENA+ was cited recently by Deputy Prime Minister Mr Heng Swee Keat as one of key healthcare projects in Singapore's National AI Strategy.

On 5 March 2020, during the MOH Committee of Supply debate, SELENA+ was also cited as an example of an innovative technology to tackle healthcare challenges by Singapore’s Minister of Health Mr Gan Kim Yong, “One example we are already deploying is the Singapore Eye Lesion Analyser Plus (SELENA+). This is a deep-learning artificial intelligence software system which can detect three major eye conditions: diabetic eye disease, glaucoma and age-related macular degeneration. SELENA+ highlights areas with potential vision threatening eye disease and refers abnormal cases to human graders, allowing them to focus on the more complex cases. SELENA+ has proven to be more efficient in delivering fast and accurate results.”

Stock

3 weeks ago | Report Abuse

EyRIS ( Selena + ) - 9 Certifications
1) CE Mark
2) Singapore HSA
3) Malaysia MDA
4) Indonesia FDA
5) Thai FDA
6) Brazil ANVISA
7) Australian TGA
8) South Africa SAPHRA
9) UAE MOHP